Quality assurance according to GMP standards
"Akrikhin" is the first Russian company, which received in 1999 the Certificate of the European Union GMP (Good Manufacturing Practice standards) for the industrial production of cardiovascular drugs, created in cooperation with the American pharmaceutical company "Bristol-Myers Squibb." Since then, the company runs regular audits of "Bristol-Myers Squibb", audits of quality assurance of other foreign pharmaceutical companies, and regulatory authorities audits for compliance with Russian and international quality standards.
In 2003, according to the results of inspection on the program of anti-TB drugs of "Akrikhin", hold by the World Health Organization (WHO), was issued the Conclusion on the compliance of quality assurance system with the requirements of the WHO GMP.
"Akrikhin" regularly and successfully passes the recertification audits of the quality management system, conducted by the Association for certification "RUSSIAN REGISTER". In December 2013 was received a regular confirmation of the Certificate of "Akrikhin" Quality management system compliance with the requirements of GOST R ISO 9001-2008.
In total, between 2000 and 2014, the company has successfully passed more than 30 quality audits, which resulted in a positive opinion on the Quality assurance and Quality management system of "Akrikhin" compliance with ISO and GMP standards.
In 2010, "Akrikhin" has launched a large-scale investment program for the development and modernization of the industrial complex of the company with a total investment of $ 40 million for 2010-2015.
In May 2015, "Akrikhin" received from the Industry and Trade Ministry of Russia the Conclusion on compliance with GMP standards.
Successfully operating and constantly developing Quality management system of the company, and its compliance with national and international requirements and standards guarantee efficacy and safety of "Akrikhin" products.